Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03159247 · ClinicalTrials.gov registry record · NA
The eyeGuide: Improving Glaucoma Self-management With a Personalized Behavior Change Program
A NA study of Glaucoma and Medication Adherence, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 107
- Enrollment target
- 1
- Study location
NCT03159247: Completed NA study of Glaucoma and Medication Adherence, sponsored by University of Michigan.
NCT03159247 is a NA study of Glaucoma and Medication Adherence that has completed, run by University of Michigan. The registered enrollment target is 107 participants, below the 909-participant average among 92 other Glaucoma trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03159247, a NA study of Glaucoma and Medication Adherence, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 107 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to test the impact of two personalized technology based programs that may help improve adherence to glaucoma medications.
Primary Outcome
electronic medication monitoring
Conditions Studied
Interventions
- BEHAVIORAL eyeGuide
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2017-01-12 |
| Est. Completion | 2020-01-10 |
| Phase | NA |
What the finished NCT03159247 record still lists
NCT03159247 is an interventional study that assigns participants to a tested intervention. The registered 107 participants enrollment target is mid-sized for trials with a published cap, below the 909-participant average among 92 other Glaucoma trials with a reported enrollment target (88% lower).
The record links to 2 conditions, with Glaucoma appearing as the primary indexed condition, and to 1 intervention - of which eyeGuide is the first listed.
NCT03159247 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT03159247 about?
NCT03159247 is a clinical study titled "The eyeGuide: Improving Glaucoma Self-management With a Personalized Behavior Change Program". The purpose of this research study is to test the impact of two personalized technology based programs that may help improve adherence to glaucoma medications.
What is the current status of trial NCT03159247?
This trial is currently completed. It is a NA study. The enrollment target is 107 participants. The study started on 2017-01-12. Estimated completion is 2020-01-10.
What conditions does trial NCT03159247 study?
This clinical trial studies the following conditions: Glaucoma, Medication Adherence.
What interventions are being tested in trial NCT03159247?
The interventions under investigation include: eyeGuide (BEHAVIORAL).
Who is sponsoring clinical trial NCT03159247?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03159247 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glaucoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03159247's enrollment target sits among peer trials
107 43rd of 92 higher than 50 of 92 other Glaucoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Glaucoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
Tolerability of an Anesthesia-free Tonometer Tip
RECRUITING · NA
-
Electrical Stimulation for the Treatment of Optic Neuropathies
RECRUITING · NA
-
The Role of Music in Enhancing Attention During Visual Field Exams for Pediatric Glaucoma Patients
RECRUITING · NA
-
Electrical Stimulation for the Treatment of Glaucoma
RECRUITING · NA
-
Hyperbaric Oxygen Therapy for Optic Neuropathies
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05491668 · 107 participants
Physiological Assessment of Severe Coronary Stenosis for Informing Planned PCI
- NCT06041594 · 107 participants · NA
Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)
- NCT06081426 · 107 participants · NA
Examining Neurobiological Mechanisms Underlying the Therapeutic Effect of the Ketogenic Diet in Bipolar Disorder (BD)
- NCT06527599 · 107 participants · NA
Screening in Trauma for Opioid Misuse Prevention - an Adaptive Intervention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI